Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vertex Pharmaceuticals
(NQ:
VRTX
)
477.37
+5.37 (+1.14%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vertex Pharmaceuticals
< Previous
1
2
3
4
5
6
7
8
9
...
51
52
Next >
Is Vertex Pharmaceuticals' Monopoly in Danger?
July 25, 2024
As a shareholder, I am nowhere close to panic mode.
Via
The Motley Fool
Why VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX) qualifies as a quality stock.
July 25, 2024
Is VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX) suited for quality investing?
Via
Chartmill
3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow
July 25, 2024
Vertex shares have soared by triple-digit percentages over the past three years.
Via
The Motley Fool
7 Biotech Stocks to Keep on Your Clinical Radar
July 23, 2024
Biotech stocks have always been relevant. However, with the latest shift in the political race, this sector is bound to grab more eyeballs.
Via
InvestorPlace
Here's How Much $100 Invested In Vertex Pharmaceuticals 5 Years Ago Would Be Worth Today
July 23, 2024
Via
Benzinga
3 Gene Editing Stocks Shaping the Future of Medicine
July 22, 2024
Gene editing stocks offer a bold venture into biopharma's future, leveraging CRISPR technology for transformative healthcare solutions
Via
InvestorPlace
Forecasting The Future: 13 Analyst Projections For Vertex Pharmaceuticals
July 11, 2024
Via
Benzinga
Check Out What Whales Are Doing With VRTX
July 10, 2024
Via
Benzinga
Why the quality investor may take a look at NASDAQ:VRTX.
July 03, 2024
Examining the Quality Attributes of NASDAQ:VRTX.
Via
Chartmill
2 Historically Flawless Metrics Suggest the Stock Market Can Plunge: Here Are 3 Stocks I've Sold Ahead of What May Be a Big Move for Wall Street
July 21, 2024
Neither of these predictive indicators has ever been wrong when back-tested for more than 150 years!
Via
The Motley Fool
3 Monster Stocks in the Making to Buy Right Now
July 20, 2024
They're small now, but these stocks could grow much larger.
Via
The Motley Fool
The 3 Best Neuroscience Biotech Stocks to Buy Now
July 19, 2024
Given the high bar to developing good neuroscience drugs, firms that do so will likely succeed. Here are three top biotech stocks to buy now.
Via
InvestorPlace
Looking for growth without the hefty price tag? Consider NASDAQ:VRTX.
July 19, 2024
VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX) is not too expensive for the growth it is showing.
Via
Chartmill
3 Gene Editing Stocks That Could Grow Your Wealth
July 17, 2024
Investors looking for gene editing stocks of cutting edge technology firms should consider these biotech stocks.
Via
InvestorPlace
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?
July 16, 2024
CRISPR Therapeutics could start reporting product revenue soon.
Via
The Motley Fool
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
July 15, 2024
These innovative drugmakers are hard to ignore.
Via
The Motley Fool
Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split
July 15, 2024
Revenue is climbing at these two drug companies -- and the trend should continue.
Via
The Motley Fool
Got $1,000? 2 Incredible Growth Stocks to Buy and Hold Forever
July 14, 2024
These companies have what it takes to stand the test of time in a portfolio.
Via
The Motley Fool
The 3 Most Undervalued Gene Editing Stocks to Buy in July 2024
July 09, 2024
Finding undervalued gene editing stocks is easy, but having the patience to stick with them is the challenge.
Via
InvestorPlace
Healthcare Stocks Continue To Lag The Market-Can Anything Help ?
July 08, 2024
Healthcare stocks continue to lag the market up about 6% YTD, helped by Large Cap Biopharma but hurt by United Health.
Via
Talk Markets
3 No-Brainer Stocks to Buy in July
July 08, 2024
Investors shouldn't have to think too hard about these great stocks.
Via
The Motley Fool
3 Pharma Stocks Already Ushering in the Next Biotech Boom
July 08, 2024
So long as diseases afflict the human condition, there will likely always be a need for pharma stocks. Here are three to consider.
Via
InvestorPlace
Prediction: This Will Be Vertex Pharmaceuticals' New Billion-Dollar Growth Driver (and It's Coming Soon).
July 06, 2024
Vertex shares have advanced by triple digits over the past few years.
Via
The Motley Fool
The 3 Best Biotech Stocks to Buy in July 2024
July 05, 2024
For investors looking for promising biotech investments should explore the best biotech stocks to watch in July 2024.
Via
InvestorPlace
1 Stock That Increased 10,000% in 33 Years to Buy and Hold Forever
July 05, 2024
It's not too late to get in on the act.
Via
The Motley Fool
Did Vertex Pharmaceuticals Just Invent the Next Ozempic?
July 05, 2024
Vertex Pharmaceuticals likely has a breakthrough medicine on its hands.
Via
The Motley Fool
Forget Eli Lilly: 3 Biotech Stocks to Buy Instead
July 04, 2024
Eli Lilly is a good stock to buy, but these should be even better.
Via
The Motley Fool
3 Top-Rated Gene Editing Stocks Actually Making Money
July 03, 2024
Profitable gene editing stocks make increasingly compelling investments as therapies commercialize this year and beyond.
Via
InvestorPlace
Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
July 02, 2024
The biotech sector (IBB) is trading just 3% away from its 52-week high and a significant resistance level, suggesting a potential breakout.
Via
MarketBeat
Topics
ETFs
Exposures
COVID-19
Vertex Announces FDA Acceptance of New Drug Application for Vanzacaftor/Tezacaftor/Deutivacaftor, a Next-In-Class Triple Combination Treatment for Cystic Fibrosis
July 02, 2024
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
51
52
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.